ImmunityBio, Inc. (IBRX)
5.52
+1.57
(+39.75%)
USD |
NASDAQ |
Jan 16, 16:00
6.04
+0.52
(+9.42%)
After-Hours: 20:00
ImmunityBio Profit Margin (Quarterly): -209.8% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Arbutus Biopharma Corp. | -1.46K% |
| Aveanna Healthcare Holdings, Inc. | 2.26% |
| Corcept Therapeutics, Inc. | 9.32% |
| Cytokinetics, Inc. | -15.81K% |
| Altimmune, Inc. | -380.3K% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -88.40% |
| Return on Invested Capital | -122.9% |
| Gross Profit Margin (Quarterly) | 87.12% |
| Operating Margin (Quarterly) | -173.5% |
| Return on Net Operating Assets | -152.6% |